Keytruda, which is already used to treat multiple cancers, is a type of immunotherapy that helps the body’s own immune system attack cancer cells.

Since 2015, NHS patients have received the world’s best-selling drug through a drip – or intravenous infusion – which can take more than an hour to administer in hospital.

Read more – BBC Health (4/5/26)